Moscow [Russia], July 12 (ANI): During a new study, Skoltech researchers and their colleagues from the University of Southern California performed a genetic analysis of a Russian sunflower collection.
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global bod
Washington [US], July 10 (ANI): The results of a new study suggested that nanomaterials found in consumer and health-care products can pass through the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape.
Geneva [Switzerland], July 10 (ANI): The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August.
Washington [US], July 6 (ANI): The findings of a new study suggest that nanomaterials found in consumer and health-care products can pass through the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape.
New Delhi [India], July 6 (ANI/The PRTree): "Protect Our Protectors" continues to support the immunity of our Corona Warriors for the second consecutive year, Fermenta Biotech Limited has donated Vitamin D for the benefit of Maharashtra Police personnel, as part of its initiative "Help Prote
Ahmedabad (Gujarat) [India], July 4 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Sunday visited the COVID-19 vaccine manufacturing facilities of Zydus Cadila and Hester Biosciences in Gujarat.
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
New Delhi [India], July 3 (ANI): The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter.
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon.
New Delhi [India], June 30 (ANI): Results of trials of the third booster dose of Bharat Biotech's COVID-19 vaccine Covaxin is expected to come by November this year, sources told ANI.